Published in J Med Screen on January 01, 1998
Screening for genetic haemochromatosis in blood samples with raised alanine aminotransferase. Gut (2000) 1.74
Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disorders. Eur J Hum Genet (2011) 1.57
Hereditary haemochromatosis: to screen or not. Conditions for screening are not yet fulfilled. BMJ (1999) 1.28
Serum iron levels and the risk of Parkinson disease: a Mendelian randomization study. PLoS Med (2013) 1.18
Association between hemochromatosis genotype and lead exposure among elderly men: the normative aging study. Environ Health Perspect (2004) 1.15
Variants in iron metabolism genes predict higher blood lead levels in young children. Environ Health Perspect (2008) 1.14
Environmental manganese exposure in residents living near a ferromanganese refinery in Southeast Ohio: a pilot study. Neurotoxicology (2009) 1.13
Screening for hereditary haemochromatosis should be implemented now. BMJ (2000) 1.06
Absorption of manganese and iron in a mouse model of hemochromatosis. PLoS One (2013) 0.94
Influence of iron metabolism on manganese transport and toxicity. Metallomics (2017) 0.75
Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med (1999) 11.19
Maternal serum screening for Down's syndrome in early pregnancy. BMJ (1988) 8.65
Apolipoproteins and ischaemic heart disease: implications for screening. Lancet (1994) 6.62
Association between exposure to environmental tobacco smoke and exacerbations of asthma in children. N Engl J Med (1993) 5.56
Prenatal screening for Down's syndrome with use of maternal serum markers. N Engl J Med (1992) 5.21
Development, multiplexing, and application of ARMS tests for common mutations in the CFTR gene. Am J Hum Genet (1992) 4.80
Is it time for population-based prenatal screening for fragile-X? Lancet (1993) 3.24
Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ (1989) 2.96
Improved 125I radioimmunoassay for cotinine by selective removal of bridge antibodies. Clin Chem (1985) 2.79
Urinary cotinine as marker of breathing other people's tobacco smoke. Lancet (1984) 2.74
Prenatal screening for trisomy 18 in the second trimester. Prenat Diagn (1990) 2.66
Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome. Br J Obstet Gynaecol (1988) 2.62
Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening. N Engl J Med (1994) 2.56
Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen (2000) 2.47
Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome. Br J Obstet Gynaecol (1988) 2.40
When is it appropriate to apply fetal cell isolation clinically? Am J Obstet Gynecol (1995) 2.17
Cotinine-assisted intervention in pregnancy to reduce smoking and low birthweight delivery. Br J Obstet Gynaecol (1991) 1.96
An unsuccessful cotinine-assisted intervention strategy to reduce environmental tobacco smoke exposure during infancy. Am J Dis Child (1992) 1.61
Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin. Prenat Diagn (1995) 1.60
Prevalence of thyroid deficiency in pregnant women. Clin Endocrinol (Oxf) (1991) 1.56
Second-trimester serum cotinine levels in nonsmokers in relation to birth weight. Am J Obstet Gynecol (1988) 1.49
The impact of preconception counseling on pregnancy outcomes. The experience of the Maine Diabetes in Pregnancy Program. Diabetes Care (1993) 1.47
Attaching and effacing Escherichia coli infections in calves, pigs, lambs, and dogs. J Vet Diagn Invest (1989) 1.45
Down's syndrome screening with nuchal translucency. Lancet (1997) 1.44
Prenatal screening for open neural-tube defects in Maine. N Engl J Med (1999) 1.42
Rapid detection of neonatal group B streptococcal infections by latex agglutination. J Pediatr (1980) 1.40
Lipoprotein(a) levels in peripheral atherosclerotic disease. J Vasc Surg (1995) 1.39
Why the term "carrier screening" should be abandoned. J Med Screen (1997) 1.39
Maternal serum alpha-fetoprotein, age, and Down syndrome risk. Am J Obstet Gynecol (1987) 1.39
Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A. J Med Screen (1998) 1.38
Classical density functional theory of freezing in simple fluids: numerically induced false solutions. Phys Rev E Stat Nonlin Soft Matter Phys (2001) 1.37
Use of serum cotinine to assess the accuracy of self reported non-smoking. Br Med J (Clin Res Ed) (1986) 1.36
Does preservation of the posterior chordae tendineae enhance survival during mitral valve replacement? Ann Thorac Surg (1979) 1.32
Cigarette consumption and serum cotinine in relation to birthweight. Br J Obstet Gynaecol (1987) 1.32
Population screening for haemochromatosis: a unifying analysis of published intervention trials. J Med Screen (1996) 1.31
Population screening for haemochromatosis: expectations based on a study of relatives of symptomatic probands. J Med Screen (1996) 1.29
Hereditary haemochromatosis: to screen or not. Conditions for screening are not yet fulfilled. BMJ (1999) 1.28
Lichtenstein vs anterior preperitoneal prosthetic mesh placement in open inguinal hernia repair: a prospective, randomized trial. Hernia (2003) 1.24
Young maternal age and smoking during pregnancy as risk factors for gastroschisis. Teratology (1993) 1.24
Determination of nicotine and cotinine in human serum and urine: an interlaboratory study. Toxicol Lett (1987) 1.23
A homogeneous method for genotyping with fluorescence polarization. Clin Chem (1997) 1.17
Reference distributions for the negative acute-phase serum proteins, albumin, transferrin and transthyretin: a practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal (1999) 1.14
Relation of severity of maternal hypothyroidism to cognitive development of offspring. J Med Screen (2001) 1.13
A new single nucleotide polymorphism in CAPN1 extends the current tenderness marker test to include cattle of Bos indicus, Bos taurus, and crossbred descent. J Anim Sci (2005) 1.12
Understanding and managing hypernatremic dehydration. Pediatr Clin North Am (1974) 1.11
Refinements in managing maternal weight adjustment for interpreting prenatal screening results. Prenat Diagn (1996) 1.11
Attaching and effacing Escherichia coli infection as a cause of diarrhea in young calves. J Am Vet Med Assoc (1990) 1.09
Self-limited neonatal hyperparathyroidism in familial hypocalciuric hypercalcemia. J Pediatr (1987) 1.09
Prenatal screening for cystic fibrosis. Lancet (1994) 1.07
Environmental tobacco smoke exposure during infancy. Am J Public Health (1990) 1.06
Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies. Clin Chem (1998) 1.06
Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotropin. Prenat Diagn (1992) 1.05
The reference range and within-person variability of thyroid stimulating hormone during the first and second trimesters of pregnancy. J Med Screen (2004) 1.05
Three-dimensional ultrasound examination of the fetal hands: normal and abnormal. Ultrasound Obstet Gynecol (1998) 1.04
Relation between maternal weight and serum alpha-fetoprotein concentration during the second trimester. Clin Chem (1981) 1.04
Consumer evaluation of beef of known categories of tenderness. J Anim Sci (1997) 1.03
Effects of calpastatin and micro-calpain markers in beef cattle on tenderness traits. J Anim Sci (2006) 1.02
Excretion of Mycobacaterium avium from lesions in the intestine and tonsils of infected swine. Am J Vet Res (1980) 1.01
Simultaneous fetal and maternal cotinine levels in pregnant women smokers. Am J Obstet Gynecol (1993) 1.00
The effect of smoking in pregnancy on maternal serum alpha-fetoprotein, unconjugated oestriol, human chorionic gonadotrophin, progesterone and dehydroepiandrosterone sulphate levels. Br J Obstet Gynaecol (1990) 1.00
A practical approach to laparoscopic surgery for malfunctioning peritoneal dialysis catheters. J Laparoendosc Adv Surg Tech A (1998) 1.00
Evidence for liver disease preceding amino acid abnormalities in hereditary tyrosinemia. N Engl J Med (1983) 0.99
Membrane versus bubble oxygenator for cardiac operations. A prospective randomized study. J Thorac Cardiovasc Surg (1980) 0.99
Exposure to environmental tobacco smoke measured by cotinine 125I-radioimmunoassay. Clin Chem (1989) 0.99
Effect of epinephrine and lidocaine therapy on outcome after cardiac arrest due to ventricular fibrillation. Circulation (1990) 0.98
Screening of maternal serum for fetal Down's syndrome in the first trimester. N Engl J Med (1998) 0.97
Ingestion of charcoal lighter fluid. J Pediatr (1975) 0.97
Maternal serum unconjugated estriol levels are lower in the presence of fetal Down syndrome. Am J Obstet Gynecol (1990) 0.96
Neurotrophic effect on isolated chick embryo muscle in culture. Science (1972) 0.96
Second-trimester levels of maternal urinary gonadotropin peptide in Down syndrome pregnancy. Prenat Diagn (1995) 0.96
Familial congenital disorder resembling stiff-man syndrome. Am J Dis Child (1972) 0.96
Assessment of single nucleotide polymorphisms in genes residing on chromosomes 14 and 29 for association with carcass composition traits in Bos indicus cattle. J Anim Sci (2005) 0.95
Recent advances in the study of structural materials compatibility with hydrogen. Adv Mater (2010) 0.95
Diabetic ketoacidosis in a community-based population. Mayo Clin Proc (1980) 0.95
Couple screening to avoid thalassemia: successful in Iran and instructive for us. J Med Screen (2005) 0.94
National beef tenderness survey - 2006: Assessment of Warner-Bratzler shear and sensory panel ratings for beef from US retail and foodservice establishments. Meat Sci (2007) 0.93
Reference distributions for immunoglobulins A, G, and M: a practical, simple, and clinically relevant approach in a large cohort. J Clin Lab Anal (1998) 0.93
An evaluation of analytic goals for assays of drugs: a College of American Pathologists Therapeutic Drug Monitoring Survey Study. Arch Pathol Lab Med (2001) 0.93